Pharmaceutical sector-specific exchange traded funds showed mixed results Tuesday after AbbVie (NYSE: ABBV) agreed to acquire Allergan (NYSE: AGN) for $63 billion. Among the largest pharma-specific ETFs, Invesco Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP) was up 0.1%, SPDR Pharmaceuticals ETF...